Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: ยป More



Comments (0) | Trackbacks (0) | Permalink


| 1 |

 
 
  Tags
 
psychosocial dependence issues nicotine OnTrak stratified addiction treatment substance dependence hospitalizations predictive modeling binge drinking depression screening percocet sober opiates behavioral healthcare services CIWA reduction in craving Research Across America ADD craving prescriptions oxycodone high-utilizing behavioral health substance dependence costs mental illness pain medication recovery network medical and behavioral costs UnitedHealthcare gabapentin Opioid Medications relapse prevention alcohol drinking behavioral health care urine drug screen drug abuse medical costs identification opioid buprenorphine relapse narcotic prometa heroin codeine facebook overdose cigarettes marijuana opioid overdose alcohol treatment chronic pain physician- patient relations diabetes drinking muscle relaxant morphine emergency room alcoholism placebo-controlled behavioral health care services drug treatment cocaine OxyContin cocaine treatment ER trauma hydrocodone SD health insurance PTSD smoking reducing craving drug addicts stimulants mental health ADHD health reform stress social network behavioral healthcare substance dependence health insurance SD members Catasys fentanyl methamphetamine recovery sobriety Raymond Anton drug use substance use disorder reduction in use opioid antagonist opiod-based placebo addict craving score randomized withdrawal depression data mining meth Co Occurring Disorders methadone opiod abuse Harold Urschel treatment vivitrol painkillers vicodin health plan methamphetamine dependence alcohol dependence addiction opioid abuse anxiety suboxone post-traumatic stress disorder bipolar disorder alcohol medical contract pain killers double-blind sugar drug addiction health insurance pain pills communication over-the-counter substances primary care naloxone opioid-drug interactions Journal of Psychopharmacology Opioid Treatment flumazenil hospital Health Care Utilization care coaching
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025